Literature DB >> 24297796

Intrafollicular endocrine milieu after addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization.

L L Thuesen1, A Nyboe Andersen, A Loft, J Smitz.   

Abstract

CONTEXT: The role of human chorionic gonadotropin (hCG) supplementation on the intrafollicular steroid milieu has been studied.
OBJECTIVE: The objective of the study was to assess the impact on steroid levels in follicular fluids (FFs) after different doses of hCG supplementation to recombinant FSH for controlled ovarian stimulation.
SETTING: This was a prospective randomized dose-response study conducted at Copenhagen University Hospital, Rigshospitalet, Denmark. PATIENTS: From 62 in vitro fertilization patients, 334 FFs were selected for analyses.
INTERVENTIONS: Patients were treated using a GnRH agonist protocol with recombinant FSH 150 IU/d and randomized from stimulation day 1 to supplementation with hCG: D0, 0 IU/d; D50, 50 IU/d; D100, 100 IU/d; and D150, 150 IU/d. MAIN OUTCOME MEASURE: Intrafollicular hormone concentrations in relation to treatment groups, follicular sizes, and embryo quality were measured.
RESULTS: In large follicles, hCG supplementation induced a nearly 3-fold increase of estradiol (nanomoles per liter) [D0: 1496; D50: 3138; D100: 4338; D150: 4009 (P < .001)], a significant 3-fold increase of androstenedione, and a 5-fold increase of T (nanomoles per liter) [D0: 15; D50: 38; D100: 72; D150: 56 (P < .001)]. The estradiol to T ratio decreased significantly, with the lowest ratio in D100 and the highest in D0. Large follicles giving rise to good-quality embryos had significantly higher estradiol and progesterone levels and estradiol to T, estradiol to androstenedione, and progesterone to estradiol ratios, compared with small follicles, leading to poor-quality embryos.
CONCLUSIONS: Increasing doses of hCG supplementation markedly stimulated the intrafollicular concentration of both estradiol and androgens, with a shift toward a more androgenic milieu. In large follicles with oocytes giving rise to good-quality embryos, the FFs were significantly more estrogenic than in small follicles with oocytes developing into poor quality embryos.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24297796     DOI: 10.1210/jc.2013-1528

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  Challenges and Potential for Ovarian Preservation with SERMs.

Authors:  Alison Y Ting; Brian K Petroff
Journal:  Biol Reprod       Date:  2015-03-25       Impact factor: 4.285

2.  The relationship between estradiol-progesterone alterations after ovulation trigger and treatment success in intrauterine insemination cycles.

Authors:  Tayfun Kutlu; Enis Özkaya; İlhan Şanverdi; Belgin Devranoğlu; Cansu İpekçi; Birsen Konukçu; Yavuz Şahin; Ateş Karateke
Journal:  Turk J Obstet Gynecol       Date:  2016-06-15

3.  The ratio of exogenous Luteinizing hormone to Follicle stimulating hormone administered for controlled ovarian stimulation is associated with oocytes' number and competence.

Authors:  Dragos Albu; Alice Albu
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

4.  Randomized, Controlled Pilot Study of Low-Dose Human Chorionic Gonadotropin Administration Beginning From the Early Follicular Phase for Women With Polycystic Ovarian Syndrome Undergoing Ovarian Stimulation Using the Progesterone Protocol.

Authors:  Xiuxian Zhu; Yonglun Fu
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-13       Impact factor: 5.555

5.  A Randomized Controlled Trial on the Efficacy and Safety of Low-Dose hCG in a Short Protocol with GnRH Agonist and Ovarian Stimulation with Recombinant FSH (rFSH) During the Follicular Phase in Infertile Women Undergoing ART.

Authors:  Charalampos Siristatidis; Sofoklis Stavros; Konstantinos Dafopoulos; Theodoros Sergentanis; Ekaterini Domali; Peter Drakakis; Dimitrios Loutradis
Journal:  Reprod Sci       Date:  2021-07-12       Impact factor: 3.060

Review 6.  Past, Present, and Future of Gonadotropin Use in Controlled Ovarian Stimulation During Assisted Reproductive Techniques.

Authors:  Anastasia Prodromidou; Elli Anagnostou; Depy Mavrogianni; Emmanouela Liokari; Evangelia Dimitroulia; Petros Drakakis; Dimitrios Loutradis
Journal:  Cureus       Date:  2021-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.